Bcl-2 family proteins in breast development and cancer: could Mcl-1 targeting overcome therapeutic resistance?
about
Lipopolysaccharides may aggravate apoptosis through accumulation of autophagosomes in alveolar macrophages of human silicosisActivity of distinct growth factor receptor network components in breast tumors uncovers two biologically relevant subtypesRegulation of anti-apoptotic Bcl-2 family protein Mcl-1 by S6 kinase 2MiRNA-101 inhibits breast cancer growth and metastasis by targeting CX chemokine receptor 7.N-(3-oxo-acyl) homoserine lactone inhibits tumor growth independent of Bcl-2 proteins.MUC1-C Stabilizes MCL-1 in the Oxidative Stress Response of Triple-Negative Breast Cancer Cells to BCL-2 Inhibitors.The effect of resveratrol on beta amyloid-induced memory impairment involves inhibition of phosphodiesterase-4 related signalingTargeting BCL-2 to enhance vulnerability to therapy in estrogen receptor-positive breast cancer.Synergistic effect of fisetin combined with sorafenib in human cervical cancer HeLa cells through activation of death receptor-5 mediated caspase-8/caspase-3 and the mitochondria-dependent apoptotic pathway.Imperatorin acts as a cisplatin sensitizer via downregulating Mcl-1 expression in HCC chemotherapy.Use of a MCL-1 inhibitor alone to de-bulk melanoma and in combination to kill melanoma initiating cells.Inhibition of PDE2 reverses beta amyloid induced memory impairment through regulation of PKA/PKG-dependent neuro-inflammatory and apoptotic pathwaysNanoparticle Delivery of Artesunate Enhances the Anti-tumor Efficiency by Activating Mitochondria-Mediated Cell Apoptosis.Suppressive effect of microRNA-143 in retinoblastomaKey Survival Factor, Mcl-1, Correlates with Sensitivity to Combined Bcl-2/Bcl-xL Blockade.Enantiomerically pure β-dipeptide derivative induces anticancer activity against human hormone-refractory prostate cancer through both PI3K/Akt-dependent and -independent pathways.Urokinase-type plasminogen activator receptor inhibits apoptosis in triple-negative breast cancer through miR-17/20a suppression of death receptors 4 and 5.Myeloid cell leukemia 1 (MCL-1), an unexpected modulator of protein kinase signaling during invasion.Systems modeling accurately predicts responses to genotoxic agents and their synergism with BCL-2 inhibitors in triple negative breast cancer cells.Intrinsic apoptotic pathway activation increases response to anti-estrogens in luminal breast cancers.Molecular Cell Biology of Apoptosis and Necroptosis in Cancer.Inhibition of Mcl-1 through covalent modification of a noncatalytic lysine side chain.Natural Compound Methyl Protodioscin Suppresses Proliferation and Inhibits Glycolysis in Pancreatic Cancer.MicroRNA-365 Inhibits Cell Growth and Promotes Apoptosis in Melanoma by Targeting BCL2 and Cyclin D1 (CCND1).uc.454 Inhibited Growth by Targeting Heat Shock Protein Family A Member 12B in Non-Small-Cell Lung Cancer.ERβ alters the chemosensitivity of luminal breast cancer cells by regulating p53 function.Discovery of Mcl-1 inhibitors from integrated high throughput and virtual screening
P2860
Q28392459-D17170C5-92DD-4BAF-9356-F4DD77629348Q33608593-C86B1C0F-8636-4243-AF71-BAFBDC4A6FB7Q36310873-5CFF2701-7576-47EE-9FB3-91908D5F44CCQ36544430-FB65D9D6-DE54-4506-B8C3-60E9EEAA5782Q36905804-4CA3F93E-A9F4-4A26-8392-D7D0850A58C1Q36928457-C83A8E25-9128-4E28-9FAE-C2762428BEECQ37109482-2688A383-8FDC-4EF5-A8F2-2AF1AF7D0F4BQ38563530-2BEA1503-E626-4658-929A-E75D8D16DC52Q38812002-3A468079-EBC8-4BEB-B02D-3D52007532C0Q38848505-1EE772D8-1406-45E1-918E-DFBFDE9BD874Q41470758-264E6008-40D7-4949-84FA-F48BBAB26C33Q41831293-2319CFC8-09DA-4020-82AB-A4BB6F31DC0AQ42207079-8B319669-F6DD-47C7-B1D9-3B25881FBFBAQ42356263-E1A80C5A-D6AF-4A54-9717-2E17E0A205B1Q42503679-CFA77021-C94F-426C-A1BA-3968EBFE3B3BQ47103726-84BC95D3-B1B5-48BA-B8D2-D53E0CCB610EQ47138270-20125C01-9EC4-4EBC-99EB-7593B78C8072Q47373137-82EAAEFC-1A8F-4C22-8CE2-3076D9833E0DQ48204107-61B9F1B5-4024-4012-B305-B7A21CE4F873Q49988930-A63DE0D2-C407-413D-AE63-1BC88120EEC3Q50221065-0EC70FA0-2E68-4DB0-9F7C-2CAA65420D8DQ51533605-ADAE1F28-BE97-4C22-8A21-26DB4DF8835FQ55052555-E5860BB1-926C-4CA2-9534-5A0A4CD60EF3Q55281092-0E69C039-B193-43AE-A8C3-010AAD62BE1EQ55416826-BF226E27-8B77-44D5-98BD-D3FC18198D96Q55421291-CE8489F2-FAE8-4F76-A4E3-146434958226Q56811078-E4D34AB3-D88C-45DD-9763-F3FF2F6C28DE
P2860
Bcl-2 family proteins in breast development and cancer: could Mcl-1 targeting overcome therapeutic resistance?
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Bcl-2 family proteins in breas ...... ercome therapeutic resistance?
@ast
Bcl-2 family proteins in breas ...... ercome therapeutic resistance?
@en
type
label
Bcl-2 family proteins in breas ...... ercome therapeutic resistance?
@ast
Bcl-2 family proteins in breas ...... ercome therapeutic resistance?
@en
prefLabel
Bcl-2 family proteins in breas ...... ercome therapeutic resistance?
@ast
Bcl-2 family proteins in breas ...... ercome therapeutic resistance?
@en
P2860
P921
P356
P1433
P1476
Bcl-2 family proteins in breas ...... ercome therapeutic resistance?
@en
P2093
Michelle M Williams
Rebecca S Cook
P2860
P304
P356
10.18632/ONCOTARGET.2792
P407
P5008
P577
2015-02-01T00:00:00Z
2015-02-28T00:00:00Z